Literature DB >> 15689197

Patterns of specific antimigraine drug use--a study based on the records of 18 community pharmacies.

J J H M Lohman1, M M van der Kuy-de Ree.   

Abstract

The objective of this study was, first, to characterize the usage patterns of specific antimigraine drugs, and second, to compare these in patients with one type of drug with patients with two or more types of drug. Dispensing data on triptans and ergotamine were collected from community pharmacy records over a 1-year period. In a population of approximately 168,000 specific antimigraine medication has been dispensed to 2343 patients (1.4%). Oral dosage forms were prescribed in most prescriptions (77.1%), subcutaneous injections in 9.7%, rectal suppositories in 7.1% and nasal sprays in 6.1%. We identified 292 patients (12.5%) to whom more than one type of drug was dispensed. Multiple drugs patients showed significantly higher drug consumption and deviating patterns of specific antimigraine drug usage, receiving significantly more non-oral dosage forms (32.8% vs. 20.4%, P<0.001). Our data indicate substantially suboptimal treatment of migraine patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15689197     DOI: 10.1111/j.1468-2982.2004.00843.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  5 in total

1.  Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy.

Authors:  Chiara Biagi; Elisabetta Poluzzi; Giuseppe Roberto; Aurora Puccini; Alberto Vaccheri; Roberto D'Alessandro; Domenico Motola; Nicola Montanaro
Journal:  Eur J Clin Pharmacol       Date:  2011-06-15       Impact factor: 2.953

2.  Treatment of migraine and tension-type headache in Croatia.

Authors:  Vlasta Vuković; Davor Plavec; Arijana Lovrencić Huzjan; Mislav Budisić; Vida Demarin
Journal:  J Headache Pain       Date:  2010-03-06       Impact factor: 7.277

3.  Triptans in the Italian population: a drug utilization study and a literature review.

Authors:  Alessandro Panconesi; Eleonora Pavone; Franca Vacca; Monica Vaiani; Roberto Banfi
Journal:  J Headache Pain       Date:  2008-03-04       Impact factor: 7.277

4.  Acute treatment patterns in patients with migraine newly initiating a triptan.

Authors:  Richard B Lipton; Steven C Marcus; Anand R Shewale; David W Dodick; Hema N Viswanathan; Jalpa A Doshi
Journal:  Cephalalgia       Date:  2020-03-05       Impact factor: 6.292

5.  Use and overuse of triptans in Austria - a survey based on nationwide healthcare claims data.

Authors:  Karin Zebenholzer; Walter Gall; Christian Wöber
Journal:  J Headache Pain       Date:  2018-05-18       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.